- Home
- POST vs GH Comparison
POST vs GH Comparison
Compare POST & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POST
- GH
- Stock Information
- Founded
- POST 1895
- GH 2011
- Country
- POST United States
- GH United States
- Employees
- POST N/A
- GH N/A
- Industry
- POST Packaged Foods
- GH Medical Specialities
- Sector
- POST Consumer Staples
- GH Health Care
- Exchange
- POST Nasdaq
- GH Nasdaq
- Market Cap
- POST 6.2B
- GH 4.9B
- IPO Year
- POST N/A
- GH 2018
- Fundamental
- Price
- POST $110.67
- GH $40.62
- Analyst Decision
- POST Buy
- GH Strong Buy
- Analyst Count
- POST 6
- GH 21
- Target Price
- POST $128.00
- GH $52.81
- AVG Volume (30 Days)
- POST 601.2K
- GH 2.3M
- Earning Date
- POST 05-08-2025
- GH 04-30-2025
- Dividend Yield
- POST N/A
- GH N/A
- EPS Growth
- POST 8.42
- GH N/A
- EPS
- POST 5.65
- GH N/A
- Revenue
- POST $7,884,600,000.00
- GH $773,996,000.00
- Revenue This Year
- POST $2.14
- GH $23.05
- Revenue Next Year
- POST $1.66
- GH $21.40
- P/E Ratio
- POST $19.58
- GH N/A
- Revenue Growth
- POST 1.48
- GH 28.20
- 52 Week Low
- POST $99.70
- GH $20.14
- 52 Week High
- POST $125.84
- GH $52.92
- Technical
- Relative Strength Index (RSI)
- POST 49.45
- GH 48.45
- Support Level
- POST $108.48
- GH $37.73
- Resistance Level
- POST $109.93
- GH $39.63
- Average True Range (ATR)
- POST 1.89
- GH 1.60
- MACD
- POST 0.17
- GH -0.01
- Stochastic Oscillator
- POST 69.60
- GH 60.00
About POST Post Holdings Inc.
Post Holdings Inc is an consumer packaged goods holding company. It operates in Post Consumer Brands which Includes branded and private label ready-to-eat cereals, Weetabix Includes the businesses of Weetabix Limited, which Post acquired in July 2017 and which produces and distributes branded and private label RTE cereal, hot cereals and other cereal-based food products, Foodservice which Includes egg and potato products in the foodservice and food ingredient channels from the businesses of MFI Holding Corporation, lastly Refrigerated Retail segment Provides refrigerated retail products, inclusive of side dishes, eggs and egg products, sausage, cheese and other dairy and refrigerated products.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.